Accelerated drug approvals present a mounting challenge to oncologists and raises concerns about cost effectiveness for health system finance leaders
In the past year, Americans have witnessed two extremes of the FDA’s accelerated approval process, exposing both profound strengths and worrisome weaknesses. Finance leaders should keep informed about new drug treatment options, their associated costs and efficacy and whether lower-cost alternatives that have the same efficacy are available so they can engage in meaningful conversations with clinicians about which options truly promote cost effectiveness of health.
Payvider Survey Summary Report
HFMA, with sponsorship from Guidehouse, surveyed over 100 health system CFOs and finance and managed care executives to understand payvider model trends. The survey indicates that provider organizations are gravitating towards risk-based payment models. Nearly 60% of health systems responding to the survey plan to advance into risk-based Medicare Advantage models this year. Survey respondents…
Healthcare 2030: The Chartis Group and Bank of America discuss embracing disruptors and rethinking care delivery
Melissa McCain, director and leader of the consumer access digital transformation practice of The Chartis Group, and Charles Alston, market executive leader of Bank of America’s healthcare team in the southeastern U.S., discuss HFMA’s Healthcare 2030 series and share insights about what hospitals and health systems should be considering as they plan for the next decade.
Healthcare 2030: The Chartis Group and Bank of America discuss embracing disruptors and rethinking care delivery
Listen to the podcast. On this episode of HFMA’s Voices in Healthcare Finance podcast, Melissa McCain, director and leader of the consumer access digital transformation practice of The Chartis Group and Charles Alston, market executive leader of Bank of America’s healthcare team in the southeastern U.S., discussed HFMA’s Healthcare 2030 series and what hospitals and…
Hospital margins increased in November, but labor expenses remained a drag on finances
A skewed labor market continued to affect hospital finances in November even as operating margins improved from October.
What would you do if your best employee quit tomorrow? Anton Gunn shares the secrets to effective succession planning
Leadership consultant Anton Gunn discusses why succession planning is important not only for C-suite executives but everyone in an organization. He also shares insights about how to train and develop up-and-coming leaders either to take over or to leave the organization for a better opportunity.
5 keys to succession planning with leadership consultant Anton Gunn
Listen to the podcast. Imagine for a moment that you win the lottery tonight. Congratulations! You’re off to Tahiti, and it’s goodbye to the day job. Have you thought about who’s going to take your place? Now, imagine your boss bought a lottery ticket and has pulled you aside to say, “If I win big,…
Policy analyst and hfm columnist Paul Keckley discusses the cost effectiveness of health
HFMA President and CEO Joe Fifer interviews Paul Keckley, managing editor of The Keckley Report and author of an upcoming column in hfm magazine about the economy and healthcare spending, public health and the pandemic, and the cost effectiveness of health.
The HFMA editorial team discusses the biggest healthcare stories of the year and looks ahead to 2022
HFMA's award-winning editorial team looks back on key stories from 2021 in the news, hfm magazine, HFMA's Community, the podcast and more.
Home-based care is ripe for innovation and implementation post COVID-19
Despite the havoc the COVID-19 pandemic created for hospitals, it also created an opportunity for many important lessons learned on how care can be delivered more efficiently and cost effectively in patients’ homes.